Try our business solution for free!

Aurobindo Pharma's expenditure on R&D FY 2017-2022, by type

Published by
Sanyukta Kanwal,
Sep 12, 2022
In fiscal year 2022, Aurobindo Pharma spent around 0.31 billion Indian rupees on capital expenses for research and development of pharmaceutical drugs. Recurring expenses for R&D of the company were more than 8.66 billion rupees in the same year.

Expenditure on research and development by Aurobindo Pharma Limited from financial year 2017 to 2022, by type (in billion Indian rupees)

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2022

Region

India

Survey time period

FY 2017 to FY 2022

Supplementary notes

India's financial year begins in April and ends in March. For example, FY 2020 started in April 2019 and ended in March 2020.

One Indian rupee is equal to 0.012 euros and 0.013 U.S. dollars as of September 2022.

Values have been rounded for clarity.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$69 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " GlaxoSmithKline Pharmaceuticals Limited India "

The most important statistics
The most important statistics
The most important statistics

Statistics on GlaxoSmithKline Pharmaceuticals Limited India

Overview

8

Key figures

6

Major players

5

Further related statistics

14

Further Content: You might find this interesting as well

Statistics

Topics

Merck & Co.Global pharmaceutical industryPharmaceutical industry in the U.S.PfizerNovartis
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu